Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study led by the University of Zurich has now examined in detail the way in which the treatment curbs the autoimmune disease ...
Nov 10, 2022
0
79
An international research consortium led by UC San Francisco scientists has shown significant differences between the gut bacteria profiles of multiple sclerosis (MS) patients and healthy individuals, as well as between MS ...
Sep 15, 2022
0
91
Multiple sclerosis (MS) patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts. This is the finding of a study from Uppsala University published in the journal JAMA ...
May 12, 2022
0
65
Currently available therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects. Researchers at Karolinska Institutet in Sweden have now developed a method for identifying the immune cells ...
Apr 27, 2022
0
135
A team of researchers at Atara Biotherapeutics has conducted a small Phase I clinical trial of a therapeutic called ATA188 that targets Epstein-Barr infections (EBV) as a treatment for multiple sclerosis (MS). Representatives ...
Multiple sclerosis sufferers often complain of more severe disease symptoms after consuming dairy products. Researchers at the Universities of Bonn and Erlangen-Nuremberg have now found a possible cause for this. According ...
Mar 1, 2022
1
164
A study published today by researchers at the MS Society Edinburgh Centre for MS Research found another clue to what goes wrong in MS—and what we could do to change it.
Feb 16, 2022
0
35
Scientists have long suspected—but failed to prove—a link between certain viral infections and the development of multiple sclerosis, a crippling autoimmune disease that affects nearly 1 million Americans. Now, a study ...
Feb 9, 2022
0
1797
An international team of researchers led by Karolinska Institutet in Sweden reports that cells in the central nervous system known as oligodendrocytes might have a different role in the development of multiple sclerosis (MS) ...
Feb 4, 2022
0
28
A University of Calgary study has found promising results for the generic drug hydroxychloroquine when used to treat the evolution of disability of primary progressive multiple sclerosis (MS), the least treatable form of ...
Jan 13, 2022
0
408
